当前位置:首页 - 行情中心 - 金域医学(603882) - 财务分析

金域医学

(603882)

  

流通市值:134.96亿  总市值:135.87亿
流通股本:4.60亿   总股本:4.63亿

金域医学(603882)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润-0.89亿元,每股收益-0.17元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益695377.21万元,未分配利润493262.54万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产971390.58万元,负债276013.37万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入4,538,151,376.332,996,929,115.161,466,504,705.887,189,544,739.91
营业总成本4,282,602,888.452,850,900,501.381,411,296,745.896,748,751,288.99
其他经营收益
营业利润-63,006,298.9-106,098,268.05-36,222,287.13-273,244,008.83
利润总额-82,117,770.48-109,608,128.07-37,314,360.01-438,646,517.55
净利润-88,794,076.93-96,868,140.52-34,725,978.18-414,703,700.92
每股收益
其他综合收益-8,139,141.33-8,271,686.13-1,934,363.9910,627,301.67
综合收益总额-96,933,218.26-105,139,826.65-36,660,342.17-404,076,399.25
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计6,727,870,048.766,704,565,580.686,818,528,334.747,318,237,550.29
非流动资产:
非流动资产合计2,986,035,762.083,078,939,700.783,036,381,581.423,073,656,192.2
资产总计9,713,905,810.849,783,505,281.469,854,909,916.1610,391,893,742.49
流动负债:
流动负债合计2,141,899,809.272,172,694,707.232,147,222,741.732,232,415,119.56
非流动负债:
非流动负债合计618,233,908.77662,745,089.81690,242,205.53684,406,029.88
负债合计2,760,133,718.042,835,439,797.042,837,464,947.262,916,821,149.44
所有者权益(或股东权益):
归属于母公司股东权益合计6,828,436,021.66,824,524,149.746,887,883,046.287,325,269,947.15
股东权益合计6,953,772,092.86,948,065,484.427,017,444,968.97,475,072,593.05
负债和股东权益合计9,713,905,810.849,783,505,281.469,854,909,916.1610,391,893,742.49
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计4,973,686,069.043,213,753,855.161,477,127,234.437,665,874,465.31
经营活动现金流出小计4,301,778,174.562,863,284,363.711,422,622,542.286,759,526,943.73
经营活动产生的现金流量净额671,907,894.48350,469,491.4554,504,692.15906,347,521.58
投资活动产生的现金流量:
投资活动现金流入小计69,898,072.0313,242,741.869,047,384.3116,711,899.32
投资活动现金流出小计332,678,444.24212,570,270.83106,474,281.8472,240,572.73
投资活动产生的现金流量净额-262,780,372.21-199,327,528.97-97,426,897.49-455,528,673.41
筹资活动产生的现金流量:
筹资活动现金流入小计113,745,121.5583,745,121.5527,458,021.55368,838,299.27
筹资活动现金流出小计507,482,770.74485,104,003.43429,632,269.24857,638,818.9
筹资活动产生的现金流量净额-393,737,649.19-401,358,881.88-402,174,247.69-488,800,519.63
汇率变动对现金及现金等价物的影响-6,458,287.49-7,028,422.73-1,510,271.7110,832,079.85
现金及现金等价物净增加额8,931,585.59-257,245,342.13-446,606,724.74-27,149,591.61
期末现金及现金等价物余额2,431,456,135.212,165,279,207.491,975,917,824.882,422,524,549.62
补充资料:
现金及现金等价物的净增加额--257,245,342.13--27,149,591.61
最新报告期:2025-10-10
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
中信建投贺菊颖0.231.151.292025-10-10
华创证券郑辰,李婵娟0.161.261.542025-10-06
中泰证券谢木青0.040.981.152025-09-05
中信证券宋硕,陈竹0.131.281.492025-08-27
中国银河孟熙,程培0.271.371.752025-08-24
TOP↑